Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Flebogamma“
Suchtreffer
Begriffe & Kennungen
Flebogamma DIF (previously Flebogammadif) · 4.8 · For safety information with respect to transmissible agents, see section 4.4.
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.8 · For safety information with respect to transmissible agents, see section 4.4.
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.8 · Frequencies have been evaluated according to the following convention:
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.8 · Frequency Frequency MedDRA System Organ Adverse reaction per per Class (SOC) patient infusion Infections and i
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.8 · Frequency Frequency MedDRA System Organ Adverse reaction per per Class (SOC) patient infusion Meningitis asept
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.8 · Paediatric population
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.8 · Paediatric population
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.8 · Source of the safety database from clinical trials and post-authorisation safety studies in a total of 128 pat
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.8 · Source of the safety database from clinical trials and post-authorisation safety studies in a total of 160 pat
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.8 · Summary of the safety profile
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.8 · Summary of the safety profile
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.8 · Tabulated list of adverse reactions Increase in the frequency of adverse reactions through the clinical trials
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.8 · Tabulated list of adverse reactions The table presented below is according to the MedDRA system organ classifi
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.8 · The most reported post-marketing ADRs received since the product was authorised for both concentrations were c
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.8 · The most reported post-marketing ADRs received since the product was authorised for both concentrations were c
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.8 · The safety results for 29 paediatric patients (those 17 years old) included in the PID studies were evaluate
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.8 · The safety results for 4 paediatric patients (those 17 years old) included in the PID study and the results
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.8 · The table presented below is according to the MedDRA system organ classification (SOC and Preferred Term Level
Eintrag öffnen